February 8 2022
Sanofi completes acquisition of Amunix
December 21, 2021
Sanofi to acquire Amunix immuno-oncology pipeline with next generation Conditionally Activated Biologics
October 7, 2021
Amunix Presents Preclinical Data on Its XPAT T Cell Engager Platform at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics
June 23, 2021
Amunix Appoints Industry Veteran, Frank Watanabe, to its Board of Directors
May 13, 2021
Amunix Expands its Board of Directors with the Appointment of Industry Veteran, Ciara Kennedy, Ph.D., M.B.A.
Director, Corporate Development
Amunix Pharmaceuticals, Inc.
2 Tower Pl #1100,
South San Francisco, CA 94080